| SC 13G | 2024-02-13 | UBS ASSET MANAGEMENT AMERICAS INC | ALCON INC | 25,782,426 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-01 | BlackRock Inc. | ALCON INC | 36,716,155 | 7.3% | EDGAR |
| SC 13G | 2023-02-23 | BlackRock Inc. | ALCON INC | 29,467,956 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-10 | WCM INVESTMENT MANAGEMENT, LLC | ALCON INC | 18,489,695 | 3.8% | EDGAR |
| SC 13G | 2022-09-08 | BlackRock Inc. | ALCON INC | 32,209,227 | 6.6% | EDGAR |
| SC 13G/A | 2022-02-10 | WCM INVESTMENT MANAGEMENT, LLC | ALCON INC | 26,016,575 | 5.2% | EDGAR |
| SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | ALCON INC | 11,815,454 | 2.4% | EDGAR |
| SC 13G/A | 2021-02-16 | Capital Research Global Investors | ALCON INC | 6,812,420 | 1.4% | EDGAR |
| SC 13G/A | 2020-09-10 | PRICE T ROWE ASSOCIATES INC /MD/ | ALCON INC | 24,628,795 | 5.0% | EDGAR |
| SC 13G | 2020-02-14 | Capital Research Global Investors | ALCON INC | 31,824,542 | 6.5% | EDGAR |
| SC 13G | 2020-01-10 | PRICE T ROWE ASSOCIATES INC /MD/ | ALCON INC | 49,485,111 | 10.1% | EDGAR |
| SC 13D/A | 2011-03-25 | NOVARTIS AG | ALCON INC | 244,207,279 | 80.8% | EDGAR |
| SC 13D/A | 2011-03-15 | NOVARTIS AG | ALCON INC | 240,827,279 | 79.6% | EDGAR |
| SC 13D/A | 2011-03-01 | NOVARTIS AG | ALCON INC | 237,357,279 | 78.5% | EDGAR |
| SC 13D/A | 2011-02-10 | NOVARTIS AG | ALCON INC | 233,777,279 | 77.3% | EDGAR |
| SC 13D/A | 2010-12-15 | NOVARTIS AG | ALCON INC | 230,137,500 | 76.2% | EDGAR |
| SC 13D/A | 2010-08-30 | NOVARTIS AG | ALCON INC | 230,137,500 | 76.6% | EDGAR |
| SC 13D/A | 2010-01-04 | NOVARTIS AG | ALCON INC | 74,061,237 | 24.8% | EDGAR |
| SC 13D | 2008-07-14 | NOVARTIS AG | ALCON INC | 74,061,237 | 24.8% | EDGAR |
| SC 13G/A | 2008-02-14 | AXA FINANCIAL INC | ALCON INC | 14,292,917 | 4.8% | EDGAR |